Glenmark gets FDA nod for generic Epiduo

Press enter to search
Close search
Open Menu

Glenmark gets FDA nod for generic Epiduo

By Sandra Levy - 11/11/2019

Glenmark has received the Food and Drug Administration’s green light for adapalene and benzoyl peroxide gel, in a dosage strength of 0.1%|2.5%.

The product is the generic of Galderma’s Epiduo gel, 0.1%|2.5%.

Epiduo gel had a market value of roughly $33.7 million for the 12 month period ending September 2019, according to IQVIA. 

      

RELATED TOPICS